Brief: IX Biopharma posts qtrly loss for the financial period of S$3 mln
23/08/2017 11:13
Aug 23 (Reuters) - IX Biopharma Ltd IXBI.SI
* Qtrly revenue S$1.8 million, up 5 pct
* Qtrly loss for the financial period S$3 million versus
profit of S$401,000
Source text for Eikon: ID:nSNZty494
Further company coverage: IXBI.SI
((Bangalore.newsroom@thomsonreuters.com;))
Recent news on IX Biopharma
See all newsBrief: Ix Biopharma Confirms Orion Not Yet Obtained Licence From Nevada State Board Of Pharmacy
Brief: Ix Biopharma Says U.S. Govt Opens Emergency Pathway, Clears Path For Wafermine Application For EUA
Brief: IX Biopharma Says Co Will Undertake An Internal Restructuring Of Its Consumer Business
Brief: IX Biopharma To Issue 1 MLN New Shares To Anson Properties At S$0.4215 Per Share
Brief: IX Biopharma Says US Government Awards US$41 MLN Contract To Fund Development Of Wafermine